Simó, Rafael
Universitat Autònoma de Barcelona · Instituto de Salud Carlos III · Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · Vall d'Hebron Institut de Recerca · Centro de Investigación Biomédica en Red
25 papers on CoChatORCID 0000-0003-0475-3096
Most cited papers
- Verified
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
on behalf of the Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group, Russell-Jones, D., Vaag, A., Schmitz, O., Sethi, B. K., Lalic, N., Antic, S., Zdravkovic, M., Ravn, G. M., & Simó, R. (2009) · Diabetologia
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 835
- Verified
Screening for diabetic retinopathy: new perspectives and challenges
Vujosevic, S., Aldington, S. J., Silva, P., Hernández, C., Scanlon, P., Peto, T., & Simó, R. (2020) · The Lancet Diabetes & Endocrinology
Retinal Imaging and AnalysisRetinal Diseases and Treatments
Cited by 671
- Verified
Effects of sotagliflozin added to insulin in patients with type 1 diabetes
Garg, S. K., Henry, R. R., Banks, P., Buse, J. B., Davies, M. J., Fulcher, G. R., Pozzilli, P., Gesty-Palmer, D., Lapuerta, P., Simó, R., et al. (2017) · New England Journal of Medicine
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 417
- Verified
Novel insights in SHBG regulation and clinical implications
Simó, R., Sáez-López, C., Barbosa-Desongles, A., Hernández, C., & Selva, D. M. (2015) · Trends in Endocrinology & Metabolism
Hormonal and reproductive studiesEstrogen and related hormone effects
Cited by 335
- Verified
Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
Vilsbøll, T., Bain, S. C., Leiter, L. A., Lingvay, I., Matthews, D., Simó, R., Helmark, I. C., Wijayasinghe, N., & Larsen, M. (2018) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementRetinal Diseases and Treatments
Cited by 318
- Verified
Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes
Hernández, C., Bogdanov, P., Corraliza, L., García-Ramírez, M., Solà-Adell, C., Arranz, J. A., Arroba, A. I., Valverde, A. M., & Simó, R. (2016) · Diabetes
Retinal Diseases and TreatmentsDiabetes Treatment and Management
Cited by 267
- Verified
Integrated image-based deep learning and language models for primary diabetes care
Li, J., Guan, Z., Wang, J., Cheung, C. Y., Zheng, Y., Lim, L.-L., Lim, C. C., Ruamviboonsuk, P., Raman, R., Corsino, L., et al. (2024) · Nature Medicine
Artificial Intelligence in Healthcare and EducationMachine Learning in Healthcare
Cited by 250
- Verified
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: A randomised, double-blind, placebo-controlled, phase 2 trial
von Herrath, M., Bain, S. C., Bode, B., Clausen, J. O., Coppieters, K., Gaysina, L., Gumprecht, J., Hansen, T. K., Mathieu, C., Morales, C., et al. (2021) · The Lancet Diabetes & Endocrinology
Diabetes and associated disordersPancreatic function and diabetes
Cited by 186
- Verified
Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review
Pearce, I., Simó, R., Lövestam‐Adrian, M., Wong, D. T., & Evans, M. (2019) · Diabetes, Obesity and Metabolism
Retinal Diseases and TreatmentsDiabetes Management and Research
Cited by 180
- Verified
Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance
Vendrell, J., El Bekay, R., Peral, B., García-Fuentes, E., Megia, A., Macias-Gonzalez, M., Real, J. F., Jimenez-Gomez, Y., Escoté, X., Pachón, G., et al. (2011) · Endocrinology
Adipokines, Inflammation, and Metabolic DiseasesDiabetes Treatment and Management
Cited by 173
- Verified
Relationship between Central Obesity and the incidence of Cognitive Impairment and Dementia from Cohort Studies Involving 5,060,687 Participants
Tang, X., Zhao, W., Lu, M., Zhang, X., Zhang, P., Xin, Z., Sun, R., Tian, W., Cardoso, M. A., Yang, J., et al. (2021) · Neuroscience & Biobehavioral Reviews
Dementia and Cognitive Impairment ResearchMenopause: Health Impacts and Treatments
Cited by 154
- Verified
The Association Between Diabetes Mellitus and Risk of Sarcopenia: Accumulated Evidences From Observational Studies
Qiao, Y.-S., Chai, Y.-H., Gong, H.-J., Zhuldyz, Z., Stehouwer, C. D. A., Zhou, J.-B., & Simó, R. (2021) · Frontiers in Endocrinology
Nutrition and Health in AgingDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 132
- Verified
Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours
Fernández‐Real, J. M., Ricart Engel, W., Simó, R., Salinas, I., Webb, S. M., & and the Study Group of Incidental Adrenal Adenoma (1998) · Clinical Endocrinology
Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders
Cited by 109
- Verified
Artificial intelligence for diabetes care: current and future prospects
Sheng, B., Pushpanathan, K., Guan, Z., Lim, Q. H., Lim, Z. W., Yew, S. M. E., Goh, J. H. L., Bee, Y. M., Sabanayagam, C., Sevdalis, N., et al. (2024) · The Lancet Diabetes & Endocrinology
Artificial Intelligence in Healthcare and EducationDiabetes Management and Research
Cited by 106
- Verified
A compartmentalized microfluidic chip with crisscross microgrooves and electrophysiological electrodes for modeling the blood–retinal barrier
Yeste, J., García-Ramírez, M., Illa, X., Guimerà, A., Hernández, C., Simó, R., & Villa, R. (2018) · Lab on a Chip
3D Printing in Biomedical ResearchMicrofluidic and Capillary Electrophoresis Applications
Cited by 89
- Verified
GLP-1R as a Target for the Treatment of Diabetic Retinopathy: Friend or Foe?
Simó, R., & Hernández, C. (2017) · Diabetes
Diabetes Treatment and ManagementRetinal Diseases and Treatments
Cited by 86
- Verified
Sex Hormone-Binding Globulin Reduction in Metabolic Disorders May Play a Role in NAFLD Development
Sáez‐López, C., Barbosa-Desongles, A., Hernández, C., Dyer, R., Innis, S. M., Simó, R., & Selva, D. M. (2017) · EndocrinologyJN
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 71
- Verified
Eating disorders are frequent among type 2 diabetic patients and are associated with worse metabolic and psychological outcomes: results from a cross-sectional study in primary and secondary care settings
Nicolau, J., Simó, R., Sanchís, P., Ayala, L., Fortuny, R., Zubillaga, I., & Masmiquel, L. (2015) · Acta Diabetologica
Eating Disorders and BehaviorsNutrition, Health and Food Behavior
Cited by 60
- Verified
Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study
Simó, R., Guerci, B., Schernthaner, G., Gallwitz, B., Rosas-Guzmàn, J., Dotta, F., Festa, A., Zhou, M., & Kiljański, J. (2015) · Cardiovascular Diabetology
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 47
- Verified
Sex hormone-binding globulin overexpression protects against high-fat diet-induced obesity in transgenic male mice
Saez-Lopez, C., Villena, J. A., Simó, R., & Selva, D. M. (2020) · The Journal of Nutritional Biochemistry
Adipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity
Cited by 38
- Verified
Efficacy and safety of once-daily insulin degludec/insulin aspart versus insulin glargine (u100) for 52 weeks in insulin-naïve patients with type 2 diabetes: A randomized controlled trial
Kumar, A., Franek, E., Wise, J., Niemeyer, M., Mersebach, H., & Simó, R. (2016) · PLOS ONE
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 38
- Verified
Clinical significance of RET/PTC and p53 protein expression in sporadic papillary thyroid carcinoma
Zafon, C., Obiols, G., Castellví, J., Tallada, N., Baena, J. A., Simó, R., & Mesa, J. (2007) · Histopathology
Thyroid Cancer Diagnosis and TreatmentThyroid and Parathyroid Surgery
Cited by 31
- Verified
Calorie restriction prevents diet‐induced insulin resistance independently of PGC‐1‐driven mitochondrial biogenesis in white adipose tissue
Pardo, R., Vilà, M., Cervela, L., de Marco, M., Gama-Pérez, P., González-Franquesa, A., Statuto, L., Vilallonga, R., Simó, R., Garcia-Roves, P. M., et al. (2019) · The FASEB Journal
Adipose Tissue and MetabolismMetabolism, Diabetes, and Cancer
Cited by 27
- Verified
Switching from treatment with sensor augmented pump to hybrid closed loop system in type 1 diabetes: impact on glycemic control and neuropsychological tests in the real world
Amigó, J., Ortiz-Zúñiga, Á., de Urbina, A. M. O., Sánchez, M., Dos-Santos, M., Abad, M., Cuadra, F., Simó, R., Hernández, C., & Simó-Servat, O. (2023) · Diabetes Research and Clinical Practice
Diabetes Management and ResearchDiabetes Management and Education
Cited by 15
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free